Publications

Read Now

07 Feb 2014
News

Let the Games Begin

August 2019 (Revised February 2020)
Case

New Hope Liuhe: Building an Integrated Agri-Food Business

By: Forest L. Reinhardt, Shu Lin, Natalie Kindred and Nancy Hua Dai

In October 2018, LIU Chang (Angela), chairman of Beijing-based New Hope Liuhe (NHL), was considering the strategy of the firm. With $9 billion in sales and a presence in nearly 20 countries, NHL was China’s largest animal feed producer and a major pork and poultry... View Details

2023
Article

Moral Escalation: Contested Category Emergence and Its Consequences in the Toy Industry

By: Ryann Noe

Preexisting research has outlined the cognitive, competitive, and economic barriers to market category emergence. Yet scholars have paid scant attention to the processes and consequences of moral resistance to nascent categories. Through a longitudinal, qualitative... View Details

Keywords: Moral Sensibility; Market Entry and Exit; Product Positioning; Technology Industry; Consumer Products Industry

Register to Read

August 1999 (Revised January 2002)
Case

Brita Products Company, The

By: John A. Deighton

Clorox's Brita skillfully exploits a tide of water safety concerns, growing a home water (filtration) business from inception to a 15% U.S. household penetration in ten years. The dilemma in the case arises as the period of increasing returns seems to be drawing to a... View Details

Keywords: Customer Value and Value Chain; Acquisition; Retention; Safety; Natural Environment; Emerging Markets; Investment Return; Equity; Demand and Consumers; United States

March 2006 (Revised November 2010)
Background Note

Protecting Foreign Investors

By: Louis T. Wells Jr.

Describes the emergence of several kinds of efforts to assure the safety of foreign investment in emerging markets: international arbitration, expanded official political risk insurance, credit from government agencies, and intervention by investors' home governments.... View Details

Keywords: Foreign Direct Investment; Risk Management; Emerging Markets; Agreements and Arrangements; Business and Government Relations; Safety

February 2010 (Revised August 2010)
Case

Sheikh Mohammed and the Making of 'Dubai, Inc.'

By: Anthony Mayo, Nitin Nohria, Umaimah Mendhro and Johnathan Cromwell

Sheikh Mohammed bin Rashid Al Maktoum has converted Dubai from a sleepy little coastal village into a world-class city, famous for its ambition, drive, and economic promise. He is the founder, part-owner, and visionary behind companies such as Emirates Airlines, a... View Details

Keywords: Development Economics; Leadership Style; Emerging Markets; Personal Development and Career; Business and Community Relations; Business and Government Relations; Dubai

December 2022
Article

I Don't 'Recall': The Decision to Delay Innovation Launch to Avoid Costly Product Failure

By: Byungyeon Kim, Oded Koenigsberg and Elie Ofek

Innovations embody novel features or cutting-edge components aimed at delivering desired customer benefits. Oftentimes, however, we observe the need to recall new products shortly after their introduction. Indeed, a firm may rush an innovation to market in an attempt... View Details

Keywords: Innovation Management; Innovation And Strategy; Product Development Strategy; Product Introduction; Quality Control; Product Recalls; Game Theory; Market Timing; Innovation Strategy; Product Launch; Product Development

Find at Harvard

2008
Working Paper

Extending Producer Responsibility: An Evaluation Framework for Product Take-Back Policies

By: Michael W. Toffel, Antoinette Stein and Katharine Lee

Manufacturers are increasingly being required to adhere to product take-back regulations that require them to manage their products at the end of life. Such regulations seek to internalize products' entire life cycle costs into market prices, with the ultimate... View Details

Keywords: Product; Cost; Corporate Social Responsibility and Impact; Environmental Sustainability

SSRN

Read Now

21 Jul 2021
Research & Ideas

What Does an ESG Score Really Say About a Company?

Receiving more information can clarify the complex, but not when it comes to environmental, social, and governance (ESG) scores. A recent study shows that the more information a company discloses about its ESG practices, the more rating agencies disagree on how well... View Details

Keywords: by Kristen Senz

07 Apr 2020
Research & Ideas

What Customers Need to Hear from You During the COVID Crisis

As the COVID-19 virus pandemic began to sweep across the world, Doug McMillon and his team at Walmart watched in horror. Suddenly, they realized, tomorrow would be nothing like “business as usual” and everything in the company’s marketing... View Details

Keywords: by Jill Avery and Richard Edelman

10 Aug 2015
Research & Ideas

New Medical Devices Get To Patients Too Slowly

market has grown at a rate of 6 percent annually in the United States. Government approval of new medical devices seems slower than it needs to be, according to a new study. ©iStock.com/basha The FDA has only regulated medical devices... View Details

Keywords: by Michael Blanding; Health; Technology

29 Sep 2009
First Look

First Look: September 29

leverage during bad times. If refinancing-facilitated homeowner-equity extraction is sufficiently widespread—as it was during the years leading up to the peak of the U.S. residential real-estate market—the inadvertent coordination of leverage during a View Details

Keywords: Martha Lagace

2024
Article

Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway

By: Mateo Aboy, Cristina Crespo and Ariel Stern

Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States

Read Now

April 2014 (Revised July 2015)
Case

Sanofi Pasteur: The Dengue Vaccine Dilemma

By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud

In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details

Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France